SCHEMBL3661071

SCHEMBL3661071

O=C(Nc1ccc(O)c(C(=O)O)c1)c1ccc2ccccc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DEGS1 O15121 1/20 0.65
▸ KMT2A Q03164 8/20 0.61
▸ MEN1 O00255 7/20 0.61
▸ NPC1 O15118 7/20 0.61
▸ RAB9A P51151 7/20 0.61
▸ SIRT6 Q8N6T7 2/20 0.58
▸ NR1H4 Q96RI1 1/20 0.58
▸ ALDH1A1 P00352 2/20 0.57
▸ PKM P14618 1/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ CASP3 P42574 1/20 0.57
▸ SENP7 Q9BQF6 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ ACMSD Q8TDX5 1/20 0.56
▸ SIRT3 Q9NTG7 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ TP53 P04637 1/20 0.55
▸ PTPN11 Q06124 1/20 0.54
▸ GPR27 Q9NS67 1/20 0.54
▸ PLAU P00749 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3662655 0.94 NPC1 (0.65) DEGS1KMT2AMEN1NPC1RAB9A
SCHEMBL3657251 0.89 KMT2A (0.74) DEGS1KMT2AMEN1NPC1RAB9A
SCHEMBL3657339 0.86 KMT2A (0.69) DEGS1KMT2AMEN1NPC1RAB9A
SCHEMBL1129948 0.85 KMT2A (0.77) KMT2AMEN1NPC1RAB9ASIRT6
SCHEMBL10758235 0.83 SIRT6 (0.64) DEGS1KMT2AMEN1SIRT6ALDH1A1
SCHEMBL3654104 0.82 SIRT6 (0.59) KMT2AMEN1SIRT6ALDH1A1PKM
SCHEMBL3656661 0.82 DEGS1 (0.77) DEGS1KMT2AMEN1NPC1RAB9A
SCHEMBL3914853 0.82 PLAU (0.62) DEGS1KMT2AMEN1NPC1RAB9A
SCHEMBL23796858 0.81 SIRT6 (0.58) KMT2AMEN1SIRT6ALDH1A1PKM
SCHEMBL30418835 0.81 SIRT6 (0.58) KMT2AMEN1SIRT6ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 — — US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 — — US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 — — EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 — — WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 — — EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 — — EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 — — US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 — — US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 — — EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC DEGS1 588/4885KMT2A 998/4885MEN1 2813/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR DEGS1 21/4885KMT2A 847/4885MEN1 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback